Free Courses vs FEE courses in Disaster education and training,.

BEMA will promote free education and training over fee based training for maximum community engagement in disaster and emergency management, and resiliency building.

CDS
CEO Black Emergency Managers Association

Coursera

Coursera provides universal access to the world’s best education, partnering with top universities and organizations to offer courses for anyone to take, for free.

© 2015 Coursera Inc. All rights reserved.

Disaster Preparedness

University of Pittsburgh

Disaster Preparedness for the Health Care Professional

Johns Hopkins University

Resilience in Children Exposed to Trauma, Disaster and War: Global Perspectives

University of Minnesota

Cybersecurity and Its Ten Domains

University System of Georgia

Building an Information Risk Management Toolkit

University of Washington

Psychological First Aid

Johns Hopkins University

Global Health and Humanitarianism

University of Manchester

Planet Earth...and You!

University of Illinois at Urbana-Champaign

AIDS: Fear and Hope

University of Michigan

Sleep: Neurobiology, Medicine, and Society

University of Michigan

An Introduction to Global Health

University of Copenhagen

Discrete Optimization

The University of Melbourne

Climate Change Policy and Public Health

University of Wisconsin–Madison

Foundations for Global Health Responders

University of Colorado System

Capacity Building. African Pharmaceuticals. Time AU member nations to take control of pharmaceutical industry within the continent.

Taking control of even the generic pharma market will bring tremendous advantages to human capital, national security, and contributions to health care sector.

Time for a change not only in control of natural resources, but resources provided to well-being of all.  

BEMA

http://www.scidev.net/global/medicine/analysis-blog/private-sector-india-generic-drug-wars.html

"The African market, expected to be worth US$30 billion by 2016,"

Bringing science and development together through original news and analysis

PHARMACEUTICALS

Threats to the Pharmacy of the Developing World

Africans who depend on drugs produced on the cheap in India could pay the steepest price if proposed changes to Indian patent law are pushed through, warns Maha Rafi Atal, a PhD candidate at the University of Cambridge, United Kingdom.

Indian companies ran afoul of Big Pharma in the 1970s when they began to only recognize patents for drug-making processes, rather than products. This opened the door for Indian companies to alter processes and “reverse engineer” medications cheaply, which they began exporting to poor countries. For example, they provide about 80% of the antiretrovirals used to treat HIV/AIDS in Africa.

Now, under US pressure, India could change its laws—and that arrangement could unravel. As Aaron Motsoaledi, South Africa's health minister, said, “We regard India as the pharmacy of the developing world … They were our heroes, and if they change their laws now, we will be in big trouble in Sub-Saharan Africa.”

SciDevNet